In case of decompensated heart failure related to chemotherapy-induced
cardiomyopathy, ivabradine administration could lead to favorable
hemodynamics via the increase of stroke volume with reducing sinus heart
rate. Assessment of the overlap between the E- and A-waves facilitates
understanding the effects of ivabradine in such cases.